CXMT picks up former Qimonda rights at a time when Beijing government is prioritising creation of national champions
More than half the companies that make up the IAM/ktMINE listing of the entities with the biggest US portfolios have instructed Fish lawyers to represent them in district court disputes over the course of the last decade
A good result in a German court and the settlement of a key competitor dispute are among positive signs for the company, but US sanctions continue to cloud future
Acquirer out of Taiwan says transaction will broaden its IP portfolio and add significant R&D resources, but it is not clear just how many patents will change hands
One week after missing bond payments, display company says its top shareholder will assign it core patent rights
Seoul Semiconductor is kicking off a “new patent management strategy” with two portfolios going under the hammer later this year
Recent transfer document relating to large Big Blue portfolio contains a who’s who of licensees in rare disclosure of the company's extensive dealmaking activity
With Intel deal set to close, and as courts around the world continue to weigh in on standards debate, iPhone maker stakes out its position
Smartphone giant's LTE play makes it the latest operating company to pony up for former Pantech patents
Shenzhen ruling comes just seven months after China Star Optoelectronics went after a Chongqing-based rival for infringement
Deal with Chinese display giant is latest in a string of disposals since Atmel was acquired by Microchip Technology
Foreign companies with R&D in China may also benefit from deal opening up PCT search options
CEO: the PAE problem is only going to increase as patent strength revives under Iancu; get ready for more expansion and the era of “LOT-plus”, with SEPs a focus
But a US federal judge ruled last month that UMC and Fujian Jinhua can review Micron’s evidence against them in the Special Administrative Region
Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate
